# CAMCI: Advancing the Use of Computerized Screening in Healthcare

> **NIH NIH SB1** · PSYCHOLOGY SOFTWARE TOOLS, INC. · 2020 · $895,901

## Abstract

Cognitive dysfunction in the elderly population, ranging from simple forgetfulness to a diagnosis of
Alzheimer’s disease, can impact one’s quality of life and ability to function in daily activities. It is crucial that
decline be detected as early as possible in order to evaluate whether the cause is treatable, and to employ
appropriate treatment, if applicable. The majority of older patients rely on their primary care physician for
the bulk of their healthcare needs, but there is a lack of sensitive tools available to the physician, and there
is a lack of physician’s time to use the tools that are available, leading to a failure to provide therapeutic
intervention at the earliest stages of loss to potentially slow the progression of disease. There is a clear
need for an easy-to-use and brief assessment tool designed to target early cognitive decline, and a need to
introduce the tool to providers who most frequently care for the elderly population: Primary Care Physicians
(PCPs). Psychology Software Tools, Inc. (PST) has developed such a tool, the Computer Assessment of
Memory and Cognitive Impairment (CAMCI), a computerized screening tool for the detection of early signs
of cognitive decline, which has been shown to be more effective in the identification of patients with subtle
cognitive loss than the tool most frequently used within the PCP office (i.e., MMSE). With PST’s considerable
experience in computerized testing and working with older populations, and in accordance with PST’s
company mission to advance the fields of research and assessment, CAMCI would provide an option for
PCPs and clinicians to provide therapeutic intervention prior to a diagnosis of dementia. Recent additions
to CPT codes permit insurance reimbursement for neuropsychological testing by a computer, including time
for the physician's or clinical psychologist's interpretation and reporting. The introduction of this new revenue
stream for PCPs and clinicians, coupled with the characteristics of being brief and self-administered make
CAMCI an attractive option for improving early intervention, providing an intelligent business solution for
healthcare professionals, and a useful and effective tool that allows physicians to better evaluate and serve
their patients. The specific aims included in the current project are focused on activities required to
successfully move CAMCI to commercialization by extending support for late stage research and product
development, including regulatory strategy and intellectual property development, data collection to replicate
key studies, product extension through increasing minority representation, and development of a measure
of meaningful change. The ultimate goal is to streamline the commercialization of CAMCI, and to provide a
useful and effective tool in the detection of cognitive dysfunction to physicians, the providers of the majority
of healthcare to the elderly population, to improve efficiency and effectiveness of clinical pract...

## Key facts

- **NIH application ID:** 9759738
- **Project number:** 5SB1AG037357-06
- **Recipient organization:** PSYCHOLOGY SOFTWARE TOOLS, INC.
- **Principal Investigator:** Amy Eschman
- **Activity code:** SB1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $895,901
- **Award type:** 5
- **Project period:** 2010-06-01 → 2023-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9759738

## Citation

> US National Institutes of Health, RePORTER application 9759738, CAMCI: Advancing the Use of Computerized Screening in Healthcare (5SB1AG037357-06). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/9759738. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*